A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis

Completed · Phase 3 · Has a placebo group

Conditions studied: Rheumatoid Arthritis

In brief

The purpose of this clinical research study is to learn if abatacept is safe when co-administered with other approved rheumatoid arthritis medications.

Key facts

Study ID

NCT00048932

Run by

Bristol-Myers Squibb

People needed

1795

Starts

2002-12-01

Expected to finish

2009-10-01

Last updated by the study team

2011-11-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet criteria of American Rheumatism Association for the diagnosis of rheumatoid arthritis and the American College of Rheumatology functional classes I, II III or IV
• Participants must be taking 1 or more DMARDs and/or biologic approved for rheumatoid arthritis (RA) for at least 3 months and be on a stable dose for 28 days prior to Day 1.
• Exclusion:
• Other auto-immune disease as a main diagnosis (e.g. Systemic Lupus Erythematosus [SLE], Scleroderma)
• Active tuberculosis (TB) requiring treatment within last 3 years

Where it is running

• Local Institution — Decatur, Alabama, United States
• Local Institution — Paradise, Arizona, United States
• Local Institution — Phoenix, Arizona, United States
• Local Institution — Tucson, Arizona, United States
• Local Institution — San Francisco, California, United States
• Local Institution — Loveland, Colorado, United States
• Local Institution — Hamden, Connecticut, United States
• Local Institution — Lake Worth, Florida, United States
• Local Institution — Largo, Florida, United States
• Local Institution — Blairsville, Georgia, United States
• Local Institution — Chicago, Illinois, United States
• Local Institution — Evansville, Indiana, United States
• Local Institution — Indianapolis, Indiana, United States
• Local Institution — Wichita, Kansas, United States
• Local Institution — Louisville, Kentucky, United States
• Local Institution — New Orleans, Louisiana, United States
• Local Institution — Baltimore, Maryland, United States
• Local Institution — Cumberland, Maryland, United States
• Local Institution — Westminster, Maryland, United States
• Local Institution — Boston, Massachusetts, United States
• Local Institution — Grand Rapids, Michigan, United States
• Local Institution — Royal Oak, Michigan, United States
• Local Institution — Toms River, New Jersey, United States
• Local Institution — Los Alamos, New Mexico, United States
• Local Institution — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.